NCT05654415

Brief Summary

In the pediatric population, electroencephalographic (EEG) recordings are frequently performed in sleep, as it reduces the amount of artifacts and might activate epileptiform discharges. To date, no agreed-upon guidelines are available for hypno-induction for EEG recordings . Among the strategies used, the most commonly used are sleep deprivation, either total or partial, and the use of melatonin, alone or in combination. The investigators proposed a study aiming at evaluating the efficacy of a melatonin-based solution for sleep induction during EEG video recording VS sleep deprivation. In a randomized, crossover study, 30 pediatric patients (aged 4-10 years) will be subjected to two EEG recordings: in one they will receive the melatonin solution (5 mg), in the other they undergo only partial sleep deprivation (about 50% of physiological sleep). The primary endpoint of the study is represented by the time to fall asleep, secondary objectives are represented by frequency of epileptiform discharges, presence/absence of epileptic seizures, In addition, the levels of 6-sulfatoxymelatonina, the primary metabolite of melatonin in saliva and urine, will be determined with a validated LC-MS method.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2021

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

November 25, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 16, 2022

Completed
15 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

December 16, 2022

Status Verified

November 1, 2022

Enrollment Period

1.3 years

First QC Date

November 25, 2022

Last Update Submit

December 14, 2022

Conditions

Keywords

Oral melatoninSleep deprivationNap EEG recordingsTime to fall asleep

Outcome Measures

Primary Outcomes (2)

  • Time elapsed (in seconds) from the starting of the EEG and beginning of sleep stages at EEG recording with melatonin

    Disappearance of the background rhythm of the alpha band on the posterior regions and appearance of the physiological hypnic figures, characteristics of the N1 phase of non-REM sleep

    From 0 seconds to 1.5 hours

  • Time elapsed (in seconds) from the starting of the EEG and beginning of sleep stages at EEG recording with deprivation

    Disappearance of the background rhythm of the alpha band on the posterior regions and appearance of the physiological hypnic figures, characteristics of the N1 phase of non-REM sleep

    From 0 seconds to 1.5 hours

Secondary Outcomes (3)

  • Frequency of epileptic anomalies

    From 0 seconds to 1.5 hours

  • Clinically detectable seizures

    From 0 seconds to 1.5 hours

  • Levels of 6-sulfatoxymelatonina

    120 minutes after oral melatonin solution

Study Arms (2)

Deprivation group

EXPERIMENTAL

Sleep deprivation of 50% of physiological sleep

Other: Deprivation

Melatonin group

EXPERIMENTAL

Melatonin oral solution 5 mg 30 minutes before EEG performing

Other: Melatonin

Interventions

Each enrolled patient will be subjected to two nap EEG recordings receiving in one occasion the melatonin-based solution under study at a dosage of 5 mg

Melatonin group

Each enrolled patient will be subjected to two nap EEG recordings,in one they will be subjected to sleep deprivation

Deprivation group

Eligibility Criteria

Age4 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • pediatric patients with epilepsy aged between 4 and 10 years with normal psychomotor development and IQ\> 70;
  • stable seizure frequency in the 3 months preceding the enrollment ;
  • stable anti-seizure medications in the 3 months preceding the enrollment;
  • written informed consent from the legal representative.

You may not qualify if:

  • subjects diagnosed with obstructive sleep apnea or other sleep disorders;
  • history of neurodevelopmental disorders;
  • concomitant use of hypnotics, stimulants, systemic corticosteroids or other immunosuppressants;
  • concomitant daily use of melatonin;
  • any conditions which, in the investigator's judgment, would compromise the achievement of the study objectives;
  • refusal to sign the informed consent from the legal representative.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Child and Adolescent Epileptology Center

Pavia, 27100, Italy

Location

Related Publications (11)

  • Alix JJP, Kandler RH, Pang C, Stavroulakis T, Catania S. Sleep deprivation and melatonin for inducing sleep in paediatric electroencephalography: a prospective multicentre service evaluation. Dev Med Child Neurol. 2019 Feb;61(2):181-185. doi: 10.1111/dmcn.13973. Epub 2018 Jul 20.

    PMID: 30028504BACKGROUND
  • Eisermann M, Kaminska A, Berdougo B, Brunet ML. Melatonin: experience in its use for recording sleep EEG in children and review of the literature. Neuropediatrics. 2010 Aug;41(4):163-6. doi: 10.1055/s-0030-1267920. Epub 2010 Nov 17.

    PMID: 21086220BACKGROUND
  • Gasparini S, Sueri C, Ascoli M, Cianci V, Cavalli SM, Ferrigno G, Belcastro V, Aguglia U, Ferlazzo E; Epilepsy Study Group of the Italian Neurological Society. Need for a standardized technique of nap EEG recordings: results of a national online survey in Italy. Neurol Sci. 2018 Nov;39(11):1911-1915. doi: 10.1007/s10072-018-3525-9. Epub 2018 Aug 23.

    PMID: 30140986BACKGROUND
  • Gustafsson G, Brostrom A, Ulander M, Vrethem M, Svanborg E. Occurrence of epileptiform discharges and sleep during EEG recordings in children after melatonin intake versus sleep-deprivation. Clin Neurophysiol. 2015 Aug;126(8):1493-7. doi: 10.1016/j.clinph.2014.10.015. Epub 2014 Oct 18.

    PMID: 25453612BACKGROUND
  • Jain SV, Horn PS, Simakajornboon N, Beebe DW, Holland K, Byars AW, Glauser TA. Melatonin improves sleep in children with epilepsy: a randomized, double-blind, crossover study. Sleep Med. 2015 May;16(5):637-44. doi: 10.1016/j.sleep.2015.01.005. Epub 2015 Jan 21.

    PMID: 25862116BACKGROUND
  • Julious SA. Sample sizes for clinical trials with normal data. Stat Med. 2004 Jun 30;23(12):1921-86. doi: 10.1002/sim.1783.

    PMID: 15195324BACKGROUND
  • Liamsuwan S, Grattan-Smith P, Fagan E, Bleasel A, Antony J. The value of partial sleep deprivation as a routine measure in pediatric electroencephalography. J Child Neurol. 2000 Jan;15(1):26-9. doi: 10.1177/088307380001500106.

    PMID: 10641606BACKGROUND
  • Sander J, Shamdeen MG, Gottschling S, Gortner L, Graber S, Meyer S. Melatonin does not influence sleep deprivation electroencephalogram recordings in children. Eur J Pediatr. 2012 Apr;171(4):675-9. doi: 10.1007/s00431-011-1640-1. Epub 2011 Nov 29.

    PMID: 22124712BACKGROUND
  • Smith SJ. EEG in the diagnosis, classification, and management of patients with epilepsy. J Neurol Neurosurg Psychiatry. 2005 Jun;76 Suppl 2(Suppl 2):ii2-7. doi: 10.1136/jnnp.2005.069245. No abstract available.

    PMID: 15961864BACKGROUND
  • Wassmer E, Quinn E, Whitehouse W, Seri S. Melatonin as a sleep inductor for electroencephalogram recordings in children. Clin Neurophysiol. 2001 Apr;112(4):683-5. doi: 10.1016/s1388-2457(00)00554-x.

    PMID: 11275541BACKGROUND
  • Wassmer E, Carter PF, Quinn E, McLean N, Welsh G, Seri S, Whitehouse WP. Melatonin is useful for recording sleep EEGs: a prospective audit of outcome. Dev Med Child Neurol. 2001 Nov;43(11):735-8. doi: 10.1017/s0012162201001347.

    PMID: 11730146BACKGROUND

MeSH Terms

Conditions

EpilepsySleep Deprivation

Interventions

Melatonin

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesDyssomniasSleep Wake DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

TryptaminesIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsHormonesHormones, Hormone Substitutes, and Hormone Antagonists

Study Officials

  • Valentina De Giorgis, MD

    Child and Adolescent Epileptology Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: The patients will be subjected to two EEG recordings: in one they will receive the melatonin solution (5 mg), in the 'other they will undergo only partial sleep deprivation (about 50% of physiological sleep).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2022

First Posted

December 16, 2022

Study Start

September 1, 2021

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

December 16, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations